LEADER 03156nam  22005894a 450 
001 9910676652203321
005 20230721005358.0
010   $a1-282-03430-8
010   $a9786612034305
010   $a1-4443-0079-2
010   $a1-4443-0080-6
035   $a(CKB)1000000000722793
035   $a(EBL)416474
035   $a(OCoLC)438702413
035   $a(SSID)ssj0000217491
035   $a(PQKBManifestationID)11197224
035   $a(PQKBTitleCode)TC0000217491
035   $a(PQKBWorkID)10213260
035   $a(PQKB)11750377
035   $a(MiAaPQ)EBC416474
035   $a(EXLCZ)991000000000722793
100   $a20080228d2008      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aPain management$b[electronic resource] $eexpanding the pharmacological options /$fGary J. McCleane
210   $aChichester, England ;$aHoboken, NJ $cWiley-Blackwell$d2008
215   $a1 online resource (200 p.)
300   $aDescription based upon print version of record.
311   $a1-4051-7823-X 
320   $aIncludes bibliographical references and index.
327   $aContents; Foreword; 1 Introduction; 2 Conventional Pain Treatment; 3 Using Drugs Outside Their Licensed Indication; Part 1; 4 Topical Nitrates; 5 Topical Tricyclic Antidepressants; 6 Topical Opioids; 7 Topical Local Anesthetics; 8 Topical Glutamate Receptor Antagonists; 9 Topical, Oral, and Perineural ?-Adrenoreceptor Agonists; 10 Lamotrigine; 11 5HT[sub(3)] Antagonists; 12 Cholecystokinin Antagonists; 13 Parenteral Anti-epileptics; 14 Intravenous Lidocaine; 15 L-Carnitine; 16 Other Pharmacological Options (Botulinum, Cimetidine, Glucosamine); Part 2; 17 Neuropathic Pain
327   $a18 Complex Regional Pain Syndrome19 Joint Pain; 20 Fracture Pain; 21 Postoperative Pain; 22 Fibromyalgia; 23 Muscle Spasm and Pain; 24 Tendinopathies; 25 Low Back Pain; 26 Cancer Pain; Appendix: Suggested Doses and Modes of Administration of Novel Pharmacological Options; Index; A; B; C; D; E; F; G; H; I; K; L; M; N; O; P; Q; R; S; T; U; V; Z
330   $aConventional pharmaceutical approaches to pain management are not always successful. Using only those medications that have an official indication for a certain condition reduces substantially the chance of the patient gaining pain relief and may expose them to intolerable side effects. However evidence now exists on the use of other drugs, produced for non-pain conditions, and how they can substantially increase the chances of pain relief. Covering the most recent developments in this field, McCleane offers an alternative solution to pain treatment when conventional treatments fail.
606   $aAnalgesics
606   $aAnalgesia
606   $aPain$xTreatment
615  0$aAnalgesics.
615  0$aAnalgesia.
615  0$aPain$xTreatment.
676   $a615.783
676   $a615/.783
700   $aMcCleane$b Gary$0970575
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910676652203321
996   $aPain management$92206008
997   $aUNINA